Information sampling is the cognitive process of accumulating information before committing to a decision. Patients across numerous disorders show decreased information sampling relative to controls.
Aims:
Here, we used the Beads and the Best Choice Tasks to study the role of dopamine signaling in information sampling.
Methods:
Participants were given placebo, amisulpride, or ropinirole in each session, in a double-blind cross-over design.
Results:
We found that ropinirole (agonist) increased the number of beads drawn in the Beads Task specifically when participants faced a loss, and decreased the rank of the chosen option in the Best Choice Task.
Conclusions:
These effects are likely driven by a combination of effects at presynaptic D2 receptors, which affect dopamine release, and post-synaptic D2 receptors. Increased D2 relative to D1 receptor activation in the striatum leads to increased sampling in the loss condition in the Beads Task. It also leads to choice of a poorer ranked option in the Best Choice Task. Decreased D2 relative to D1 receptor activation leads to decreased sampling in the Beads Task in the loss condition.
Abi-DarghamAGilRKrystalJet al. (1998) Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort. Am J Psychiatry155: 761–767.
2.
AndreouCMoritzSVeithKet al. (2014) Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: A double-blind study. Schizophr Bull40: 558–565.
3.
AverbeckBBEvansSChouhanVet al. (2011) Probabilistic learning and inference in schizophrenia. Schizophr Res127: 115–122.
4.
BuschmannHDiazJLHolenzJet al. (2007) Antidepressants, Antipsychotics, Anxiolytics from Chemistry and Pharmacology to Clinical Application. New Jersey, USA: Wiley, 616.
5.
CiliaRKoJHChoSSet al. (2010) Reduced dopamine transporter density in the ventral striatum of patients with Parkinson’s disease and pathological gambling. Neurobiol Dis39: 98–104.
6.
ClarkLRobbinsTWErscheKDet al. (2006) Reflection impulsivity in current and former substance users. Biol Psychiatry60: 515–522.
7.
CostaVDAverbeckBB (2015) Frontal-parietal and limbic-striatal activity underlies information sampling in the best choice problem. Cereb Cortex25: 972–982.
CrockettMJClarkLSmillieLDet al. (2012) The effects of acute tryptophan depletion on costly information sampling: Impulsivity or aversive processing?Psychopharmacology219: 587–597.
10.
DjamshidianAO’SullivanSSFoltynieTet al. (2013) Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson’s disease. J Parkinsons Dis3: 139–144.
11.
DjamshidianAO’SullivanSSSanotskyYet al. (2012) Decision making, impulsivity, and addictions: Do Parkinson’s disease patients jump to conclusions?J Movement Disord Soc27: 1137–1145.
12.
DudleyREJohnCHYoungAWet al. (1997) Normal and abnormal reasoning in people with delusions. Br J Clin Psychol36: 243–258.
13.
ErmakovaAORamachandraPCorlettPRet al. (2014) Effects of methamphetamine administration on information gathering during probabilistic reasoning in healthy humans. PLoS One9: e102683.
14.
EvansSAlmahdiBSultanPet al. (2012) Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia. J Psychopharmacol26: 1211–1217.
15.
EvansSLAverbeckBBFurlN (2015) Jumping to conclusions in schizophrenia. Neuropsychiatr Dis Treat11: 1615–1624.
16.
FrankMJO’ReillyRC (2006) A mechanistic account of striatal dopamine function in human cognition: Psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci120: 497–517.
17.
FreemanDPughKGaretyP (2008) Jumping to conclusions and paranoid ideation in the general population. Schizophr Res102: 254–260.
18.
FurlNAverbeckBB (2011) Parietal cortex and insula relate to evidence seeking relevant to reward-related decisions. J Neurosci31: 17572–17582.
19.
GaretyPAHemsleyDRWesselyS (1991) Reasoning in deluded schizophrenic and paranoid patients. Biases in performance on a probabilistic inference task. J Nerv Ment Dis179: 194–201.
20.
GarrisPAWightmanRM (1995) Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo. Synapse20: 269–279.
21.
GoodmanLSGilmanABruntonLLet al. (2006) Goodman & Gilman’s the Pharmacological Basis of Therapeutics, New York: McGraw-Hill.
22.
GreenB (2002) Focus on amisulpride. Curr Med Res Opin18: 113–117.
23.
HaberSNFudgeJLMcFarlandNR (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci20: 2369–2382.
24.
HuqSFGaretyPAHemsleyDR (1988) Probabilistic judgements in deluded and non-deluded subjects. Q J Exp Psychol A40: 801–812.
25.
JostWHAngersbachD (2005) Ropinirole, a non-ergoline dopamine agonist. CNS Drug Rev11: 253–272.
26.
KohnoMOkitaKMoralesAMet al. (2016) Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: Link to impulsivity in methamphetamine users. Mol Psychiatry21: 1554–1560.
27.
KutnerMHNachtsheimCJNeterJet al. (2005) Applied Linear Statistical Models. New York, NY: McGraw-Hill.
28.
LeemanRFPotenzaMN (2011) Impulse control disorders in Parkinson’s disease: Clinical characteristics and implications. Neuropsychiatry (London)1: 133–147.
29.
LejarragaTHertwigR (2017) How the threat of losses makes people explore more than the promise of gains. Psychon Bull Rev24: 708–720.
30.
LewisDAFooteSLGoldsteinMet al. (1988) The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study. Brain Res449: 225–243.
31.
MoutoussisMBentallRPEl-DeredyWet al. (2011) Bayesian modelling of Jumping-to-Conclusions bias in delusional patients. Cogn Neuropsychiatry16: 422–447.
RosenzweigPCanalMPatatAet al. (2002) A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol17: 1–13.
34.
RutledgeRBSkandaliNDayanPet al. (2015) Dopaminergic modulation of decision making and subjective well-being. J Neurosci35: 9811–9822.
35.
RutledgeRBSmittenaarPZeidmanPet al. (2016) Risk taking for potential reward decreases across the lifespan. Curr Biol26: 1634–1639.
36.
SlifsteinMvan de GiessenEVan SnellenbergJet al. (2015) Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: A positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry72: 316–324.
37.
SpeechleyWJWhitmanJCWoodwardTS (2010) The contribution of hypersalience to the “jumping to conclusions” bias associated with delusions in schizophrenia. J Psychiatry Neurosci35: 7–17.
38.
SpinellaM (2003) Evolutionary mismatch, neural reward circuits, and pathological gambling. Int J Neurosci113: 503–512.
39.
SulzerDSondersMSPoulsenNWet al. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol75: 406–433.
40.
TammingaCAGerlachJ (1987) New neuroleptics and experimental antipsychotics in schizophrenia. In: MeltzerHY (ed) Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp. 1129–1140.
41.
TrifilieffPMartinezD (2014) Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology76: 498–509.
42.
Van DaelFVersmissenDJanssenIet al. (2006) Data gathering: Biased in psychosis?Schizophr Bull32: 341–351.
43.
VeckenstedtRRandjbarSVitzthumFet al. (2011) Incorrigibility, jumping to conclusions, and decision threshold in schizophrenia. Cogn Neuropsychiatry16: 174–192.
44.
VolkowNDKoobG (2015) Brain disease model of addiction: Why is it so controversial?Lancet Psychiatry2: 677–679.
45.
VolkowNDKoobGFMcLellanAT (2016) Neurobiologic advances from the brain disease model of addiction. N Engl J Med374: 363–371.
46.
ZawadzkiJAWoodwardTSSokolowskiHMet al. (2012) Cognitive factors associated with subclinical delusional ideation in the general population. Psychiatry Res197: 345–349.
